Poly Medicure Ltd.

NSE: POLYMED  SECTOR: Medical Equipment/Supplies/Accessories

705.9
-7.05 (-0.99%)

Price Summary

Today's High

₹ 731.25

Today's Low

₹ 648.8

52 Week High

₹ 751.95

52 Week Low

₹ 200.25

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

6768.20922453 Cr.

Enterprise Value

6935.42772453 Cr.

No. of Shares

9.5880567 Cr.

P/E

59.91

P/B

12.76

Face Value

₹ 5

Div. Yield

0.28%

Book Value (TTM)

₹  55.3306

CASH

22.3924 Cr.

DEBT

189.6109 Cr.

Promoter Holding

48.77%

EPS (TTM)

₹  11.7832

Sales Growth

10.1368438725359%

ROE

22.8493892957393 %

ROCE

24.6359375601041 %

Profit Growth

14.2971488282203 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year10.14%
3 Year13.71%
5 Year11.57%

Profit Growth (in Cr.)

1 Year39.37%
3 Year18.02%
5 Year8.65%

ROE%

1 Year22.85%
3 Year21.57%
5 Year22.05%

ROCE %

1 Year24.64%
3 Year24.5%
5 Year24.99%

Debt/Equity

0.4418

Price to Cash Flow

53.33

Interest Cover Ratio

7.16437031787811

CFO/PAT (5 Yr. Avg.)

1.28876273377385

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2020 48.77 0
Sep 2020 48.76 0
Jun 2020 48.76 0
Mar 2020 48.76 0
Dec 2019 48.76 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.0194006922282% for the Past 3 years.
  • Company has been maintaining healthy ROE of 21.5696546267782% over the past 3 years.
  • Company has been maintaining healthy ROCE of 24.5036673478363% over the past 3 years.
  • The Company has been maintaining an effective average operating margins of 22.8935802012536% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 78.2522134648988 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.28876273377385.

 Limitations

  • The company has shown a poor revenue growth of 13.7089795059114% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 32.9194.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 171.41 159.18 160.62 190.23 194.03
Total Expenditure 126.56 121.18 115.66 136.19 137.62
Operating Profit 44.85 38 44.96 54.04 56.41
Other Income 3.98 5.42 3.45 3.62 4.79
Interest 5.2 7.92 2.63 2.64 4.62
Depreciation 10.46 9.09 10.71 11.14 12.25
Exceptional Items 0 0 0 0 0
Profit Before Tax 33.18 26.41 35.07 43.88 44.33
Tax 8.61 5.79 9.45 10.65 10.82
Profit After Tax 24.56 20.61 25.62 33.23 33.52
Adjusted EPS (Rs) 0.28 0.23 0.29 0.38 0.38

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 394.48 439.5 508.44 586.69 646.16
Total Expenditure 308.04 345.39 386.94 452.71 483.92
Operating Profit 86.44 94.11 121.5 133.98 162.24
Other Income 8.39 13.53 14.37 16.05 18.58
Interest 9.76 8.42 11.11 13.18 19.76
Depreciation 20.19 22.96 28.41 36.36 39.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 64.88 76.26 96.36 100.49 121.78
Tax 17.57 20.06 26.16 34.21 29.4
Net Profit 47.31 56.2 70.2 66.28 92.38
Adjusted EPS (Rs.) 5.36 6.37 7.96 7.51 10.47

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 22.06 44.11 44.11 44.12 44.12
Total Reserves 201.78 225.06 290.4 335.66 385.16
Borrowings 31.06 47.62 79.12 91.38 110.57
Other N/C liabilities 18.42 23.93 24.83 26.96 23.92
Current liabilities 102.97 108.13 116.18 162.44 208.27
Total Liabilities 376.29 448.86 554.64 660.56 772.05
Assets
Net Block 177.25 200.49 256.09 268.54 324.16
Capital WIP 2.87 11.77 9.66 9.29 16.7
Investments 5.61 6.25 11.19 45.55 45.49
Loans & Advances 12.89 17.45 13.7 8.82 19.54
Other N/C Assets 14.22 12.82 14.19 19.63 40.76
Current Assets 163.44 200.08 249.81 308.73 325.4
Total Assets 376.29 448.86 554.64 660.56 772.05
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 64.88 76.26 96.36 100.49 121.78
Adjustment 24.89 21.89 37.78 40.93 50.36
Working Capital Changes -14 -24.92 -35.5 -0.74 -9.66
Tax Paid -13.89 -18.21 -23.14 -27.49 -35.58
Operating Cash Flow 61.88 55.02 75.5 113.19 126.91
Investing Cash Flow -30.25 -54.18 -87.07 -104.27 -105.67
Financing Cash Flow -30.66 -0.77 14.48 -9.69 -22.25
Net Cash Flow 0.96 0.07 2.91 -0.77 -1.02

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Poly Medicure and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 126.905 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Poly Medicure has a Debt to Equity ratio of 0.4418 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Poly Medicure , the EPS growth was 39.3586245501182 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Poly Medicure has OPM of 25.1082080913405 % which is a good sign for profitability.
     
  • ROE: Poly Medicure have a healthy ROE of 22.8493892957393 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Poly Medicure

X